首页> 美国卫生研究院文献>Frontiers in Oncology >A Single Case of Rosai–Dorfman Disease Marked by Pathologic Fractures Kidney Failure and Liver Cirrhosis Treated with Single-Agent Cladribine
【2h】

A Single Case of Rosai–Dorfman Disease Marked by Pathologic Fractures Kidney Failure and Liver Cirrhosis Treated with Single-Agent Cladribine

机译:单药克拉屈滨治疗一例以病理性骨折肾衰竭和肝硬化为特征的罗萨伊-多夫曼病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Rosai–Dorfman disease (RDD) is a proliferative histiocytic disorder of unknown etiology, which is characterized by sinus histiocytosis with massive lymphadenopathy (). In most cases, RDD has a benign course and treatment is not necessary. However, severe cases of RDD require treatment, and the treatment strategy is determined on the basis of the severity of the disease or the extranodal involvement of vital organs. We report a single case of RDD with atypical presentation of persistent constitutional symptoms, progressing pathologic fractures, and end-organ dysfunction, including acute kidney failure and liver cirrhosis with esophageal varices.
机译:Rosai-Dorfman病(RDD)是一种病因不明的增生性组织细胞性疾病,其特征是窦性组织细胞增生伴大量淋巴结病()。在大多数情况下,RDD具有良性病程,因此不需要治疗。然而,RDD的严重病例需要治疗,并且根据疾病的严重程度或重要器官的结外受累来确定治疗策略。我们报告了一例RDD,伴有典型的持续性体质症状,进行性病理性骨折和终末器官功能障碍,包括急性肾衰竭和食管静脉曲张的肝硬化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号